ENSG00000284762


Homo sapiens

Features
Gene ID: ENSG00000284762
  
Biological name :AC022414.1
  
Synonyms : AC022414.1 / high affinity cAMP-specific and IBMX-insensitive 3,5-cyclic phosphodiesterase 8B isoform 11
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 5
Strand: 1
Band: q13.3
Gene start: 77086732
Gene end: 77427124
  
Corresponding Affymetrix probe sets: 1554789_a_at (Human Genome U133 Plus 2.0 Array)   213228_at (Human Genome U133 Plus 2.0 Array)   241423_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000493971
NCBI entrez gene - 8622     See in Manteia.
OMIM - 603390
RefSeq - XM_011543701
RefSeq - XM_011543702
RefSeq - XM_011543703
RefSeq - XM_017010004
RefSeq - XM_017010006
RefSeq - XM_017010007
RefSeq - XM_005248623
RefSeq - XM_005248624
RefSeq Peptide - NP_001336682
Ensembl - ENSG00000284762
  
Related genetic diseases (OMIM): 609161 - Striatal degeneration, autosomal dominant, 609161
  614190 - Pigmented nodular adrenocortical disease, primary, 3, 614190
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 pde8bENSDARG00000063706Danio rerio
 ENSGALG00000004339Gallus gallus
 Pde8bENSMUSG00000021684Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
PDE8B / O95263 / phosphodiesterase 8BENSG00000113231100
PDE8A / O60658 / phosphodiesterase 8AENSG0000007341768
PDE4A / P27815 / phosphodiesterase 4AENSG0000006598921
PDE4B / Q07343 / phosphodiesterase 4BENSG0000018458821
PDE4C / Q08493 / phosphodiesterase 4CENSG0000010565019
PDE4D / Q08499 / phosphodiesterase 4DENSG0000011344819
Q08493 / AC008397.2 / cAMP-specific 3,5-cyclic phosphodiesterase 4C ENSG0000028518819
PDE1C / Q14123 / phosphodiesterase 1CENSG0000015467816
PDE1A / P54750 / phosphodiesterase 1AENSG0000011525215
PDE1B / Q01064 / phosphodiesterase 1BENSG0000012336015
PDE7A / Q13946 / phosphodiesterase 7AENSG0000020526815
PDE7B / Q9NP56 / phosphodiesterase 7BENSG0000017140814


Protein motifs (from Interpro)
Interpro ID Name
 IPR000014  PAS domain
 IPR002073  3"5"-cyclic nucleotide phosphodiesterase, catalytic domain
 IPR003607  HD/PDEase domain
 IPR023088  3"5"-cyclic nucleotide phosphodiesterase
 IPR023174  3"5"-cyclic nucleotide phosphodiesterase, conserved site
 IPR035965  PAS domain superfamily
 IPR036971  3"5"-cyclic nucleotide phosphodiesterase, catalytic domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0007165 signal transduction IEA
 molecular_functionGO:0004114 3",5"-cyclic-nucleotide phosphodiesterase activity IEA
 molecular_functionGO:0008081 phosphoric diester hydrolase activity IEA


Pathways (from Reactome)
Pathway description
No match


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000135 Hypogonadism "Reduced function of the gonads (testes in males or ovaries in females)." [HPO:curators]
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000822 Hypertension "High blood pressure." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0000963 Thin skin 
Show

 HP:0001065 Striae distensae "Thinned, erythematous, depressed bands of atrophic skin. Initially, striae appear as flattened and thinned, pinkish linear regions of the skin. Striae tend to enlarge in length and become reddish or purplish. Later, striae tend to appear as white, depressed bands that are parallel to the lines of skin tension. Striae distensae occur most often in areas that have been subject to distension such as the lower back, buttocks, thighs, breast, abdomen, and shoulders." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001288 Gait disturbance "The term gait disturbance can refer to any disruption of the ability to walk. In general, this can refer to neurological diseases but also fractures or other sources of pain that is triggered upon walking. However, in the current context gait disturbance refers to difficulty walking on the basis of a neurological or muscular disease." [HPO:curators]
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001533 Asthenic habitus "Asthenic habitus refers to a slender build with long limbs, an angular profile, and prominent muscles or bones." [HPO:curators]
Show

 HP:0001580 Pigmented micronodular adrenocortical disease 
Show

 HP:0002015 Dysphagia "Difficulty in swallowing." [HPO:curators]
Show

 HP:0002063 Rigidity 
Show

 HP:0002067 Bradykinesia "Bradykinesia literally means slow movement, and is used clinically to denote a slowness in the execution of movement (in contrast to hypokinesia, which is used to refer to slowness in the initiation of movement)." [HPO:curators]
Show

 HP:0002075 Dysdiadochokinesis "An inability to perform rapidly alternating movements, such as rhythmically tapping the fingers on the knee, generally related to a cerebellar lesion." [HPO:curators]
Show

 HP:0002375 Hypokinesia 
Show

 HP:0002395 Lower limb hyperreflexia 
Show

 HP:0002659 Increased susceptibility to fractures "An abnormally increased tendency to fractures of bones caused by an abnormal reduction in bone strength that is generally associated with an increased risk of fracture." [HPO:sdoelken]
Show

 HP:0003118 Increased serum cortisol 
Show

 HP:0003198 Myopathy 
Show

 HP:0003202 Amyotrophy "The presence of muscular atrophy (which is also known as amyotrophy)." [HPO:curators]
Show

 HP:0003677 Slow progression 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0007039 MRI shows symmetric lesions of the basal ganglia 
Show

 HP:0008221 Enlarged adrenal glands 
Show

 HP:0012378 Fatigue "A subjective feeling of tiredness characterized by a lack of energy and motivation." [HPO:probinson]
Show

 HP:0040140 Degeneration of the striatum 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2025
contact: otassy@igbmc.fr